Gypsy Vanner Breed Partnership Program available

Gypsy Vanner Breed Partnership Program available

Gypsy Vanner

LexLin Gypsy Ranch, the largest breeding farm for Gypsy Vanner horses in North America, has announced a new broodmare partnership program to introduce prospective owners to the Gypsy Vanner breed.

The LexLin Gypsy Breeder's Partnership Program™ offers a care lease–foal partnership program for this breed, which is indigenous to the United Kingdom.

LexLin Gypsy Ranch matches approved applicants to the most appropriate Gypsy broodmare[s] to help partners meet their goals of owning and caring for a Gypsy horse.

As part of this partnership package, LexLin Gypsy Ranch provides guidance and expertise to partners in the breeding and care of a Gypsy Vanner, a horse prized for its ideal temperament and great athleticism.

The program allows partners an opportunity to become involved with a low-risk, minimal investment, which can lead to ownership of a Gypsy Vanner.

No purchase of the broodmare is necessary, although many of the mares in the program are available for purchase.

A partner leasing mares through the program pays for all expenses related to the health and well-being of the Gypsy mares/foals in the partner's care.

In turn, the partner receives a 50 percent interest in the foal through six months of age, with the opportunity to purchase the foal for a predetermined price. All LexLin Gypsy Vanner horses are registered immediately upon purchase or birth, with DNA and color testing conducted and documented.

If the partner is not interested in purchasing LexLin Gypsy Ranch's share in the foal born through the partnership, they may assist in the sale of the horse and share in the proceeds.

Since this program launched in March 2012, more than 40 LexLin Gypsy Vanner mares have been leased by program partners throughout the United States.

Visit to view more program details and specific mares available for lease partnership.

Cette entrée a été publiée dans News et étiqueté . Ajouter aux favoris permalien.